• 
• 
• 

FDA News and Drug Updates

A Dynamic FDA Has Led to More Rapid Cancer Drug Development

Welcome to the Third Annual Oncology Guide to New FDA Approvals

FDA Approvals in 2017 Represent a 21-Year High

FDA Approvals of Brand-Name Prescription Cancer Drugs in 2017

Adverse Effects

Understanding Immunotherapy Late Adverse Effects in Cancer Survivors

Meg Barbor, MPH

Immunotherapy Combination Shows Promising Results in HER2 1+/2+ Breast Cancer

Adverse Events Associated with Checkpoint Inhibitors

Alice Goodman

View All Supportive Care Articles

Immunotherapy

NCCN Issues First Guideline for Immunotherapy-Related Adverse Events

Wayne Kuznar

CAR T-Cell Manufacturing Process Depends on Good-Quality T-Cells

Phoebe Starr

Nivolumab Shows Durable Activity in Subgroups of Patients with Metastatic CRC

Charles Bankhead

View All Breast Cancer Articles

Conference Correspondent

Palliative Care Use Dismal Among Patients with Hematologic Malignancies

Oral Multiple Myeloma Medication Linked to Decreased Productivity Loss

Ivosidenib, New IDH1 Inhibitor, Elicits Complete Response in Relapsed Acute Myeloid Leukemia

“Superhero” Navigators Convene at the 8th Annual Navigation & Survivorship Conference

Silent Patients Find Their Voices Through an Advocate’s Journey

View All Conference Correspondent Articles

Most Popular Articles

What the Next Generation of Cancer Biomarkers May Involve

Sanjiv Agarwala, MD

Video Library - 2018 ASCO Insights, Video

How MSI and TMB Factor into Current Biomarker Testing Panels

Sanjiv Agarwala, MD

Video Library - 2018 ASCO Insights, Video

How Real-World Data Are Consolidating Our Knowledge Regarding Melanoma Treatment

Sanjiv Agarwala, MD

Video Library - 2018 ASCO Insights, Video

How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for their Patients

David Spigel, MD

Video Library - 2018 ASCO Insights, Video

The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer

David Spigel, MD

Video Library - 2018 ASCO Insights, Video